logo
Monitoring of Inosine Monophosphate Dehydrogenase Activity as a Biomarker for Mycophenolic Acid Effect: Potential Clinical Implications
Analytical Methods of Biological Monitoring for Exposure to Pesticides: Recent Update
Indinavir Trough Concentration as a Determinant of Early Nephrolithiasis in HIV-1-Infected Adults
Efficacy of Low-Dose Boosted Saquinavir Once Daily Plus Nucleoside Reverse Transcriptase Inhibitors in Pregnant HIV-1-Infected Women With a Therapeutic Drug Monitoring Strategy
Influence of Underlying Disease on Busulfan Disposition in Pediatric Bone Marrow Transplant Recipients: A Nonparametric Population Pharmacokinetic Study
Dose-Dependent Effects of the 3435 C>T Genotype of ABCB1 Gene on the Steady-State Plasma Concentration of Fluvoxamine in Psychiatric Patients
Thymidylate Synthase (TYMS) and Dihydropyrimidine Dehydrogenase (DPYD) Polymorphisms in the Korean Population for Prediction of 5-Fluorouracil-Associated Toxicity
Determination of Fenofibric Acid Concentrations by HPLC After Anion Exchange Solid-Phase Extraction From Human Serum
Effects of Prior Administration of Amodiaquine on the Disposition of Halofantrine in Healthy Volunteers
Limited Sampling Strategy for the Estimation of Mycophenolic Acid Area Under the Plasma Concentration-Time Curve in Adult Patients Undergoing Liver Transplant
Determination of Free and Total Cortisol in Plasma and Urine by Liquid Chromatography-Tandem Mass Spectrometry
13C-Erythromycin Breath Test as a Noninvasive Measure of CYP3A Activity in Newborn Infants: A Pilot Study
A Simple and Sensitive High-Performance Liquid Chromatographic Method for Quantification of PXD101, a Histone Deacetylase Inhibitor in Human Plasma
Doping-Control Analysis of the 5α-Reductase Inhibitor Finasteride: Determination of Its Influence on Urinary Steroid Profiles and Detection of Its Major Urinary Metabolite
Concentrations of Scheduled Prescription Drugs in Blood of Impaired Drivers: Considerations for Interpreting the Results
Estimation of the Initial Dose Setting of Vancomycin Therapy With Use of Cystatin C as a New Marker of Renal Function
Erratum